CMC Ambroise Paré

Neuilly-sur-Seine

OncologyGrant-only

Compare Sign in to watch

What changed

Study registered, no phase assigned: ATROPOS: Survival Analysis of ICI-associated Myocarditis

5w agoTrial registeredJun 10, 2026Source filing (opens the source filing in a new tab)

Momentum

91no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

15,626 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
Study registered
May 20, 2026
Immune Checkpoint Inhibitor-associated Myocarditis · RECRUITING · sponsor: Groupe Hospitalier Pitie-Salpetriere · ATROPOS: Survival Analysis of ICI-associated Myocarditis
ClinicalTrials.gov · NCT07633587 (opens the source filing in a new tab)
Trial
Study registered
Nov 28, 2023
Cardiac Disease, Ventricular Arrythmia · RECRUITING · sponsor: Assistance Publique - Hôpitaux de Paris · Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
ClinicalTrials.gov · NCT05829993 (opens the source filing in a new tab)
Trial
Study registered
Jul 28, 2023
Breast Cancer, Ribociclib · COMPLETED · sponsor: CMC Ambroise Paré · A Deep Learning Method to Evaluate QT on Ribociclib
ClinicalTrials.gov · NCT05623397 (opens the source filing in a new tab)
Trial
Study registered
Dec 1, 2022
Anticoagulants and Thrombotic Disorders · COMPLETED · sponsor: Groupe Hospitalier Pitie-Salpetriere · Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients
ClinicalTrials.gov · NCT05819736 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the trial record at 0.50name similarity 100%

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: ATROPOS: Survival Analysis of ICI-associated Myocarditis
5w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: ATROPOS: Survival Analysis of ICI-associated Myocarditis
5w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Deep Learning Method to Evaluate QT on Ribociclib
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Deep Learning Method to Evaluate QT on Ribociclib
6w agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients
6w agoTrial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias
11mo agoTrial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources